Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
detroit blog main
3
×
detroit top stories
fda
life sciences
national blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
aducanumab
alder biopharmaceuticals
alzheimer's disease
amblyotech
amgen
asklepios biopharmaceutical
bempedoic acid
bioeurope
biogen
What
fda
3
×
medicines
3
×
drug
new
nod
activity
amgen
approval
approvals
approved
bio
biogen
candidates
cholesterol
clamped
class
combo
covid
delays
developed
developing
economic
esperion
esperion’s
fast
gets
head
including
ipo
isn’t
levels
lot
lowering
migraine
oric’s
pain
pairs
pill
preventive
regulatory
Language
unset
Current search:
medicines
×
fda
×
" detroit blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
